These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. In Vitro Synergistic Activity of Antimicrobial Agents in Combination against Clinical Isolates of Colistin-Resistant Acinetobacter baumannii. Bae S; Kim MC; Park SJ; Kim HS; Sung H; Kim MN; Kim SH; Lee SO; Choi SH; Woo JH; Kim YS; Chong YP Antimicrob Agents Chemother; 2016 Nov; 60(11):6774-6779. PubMed ID: 27600048 [TBL] [Abstract][Full Text] [Related]
11. In vitro activities of rifampin, colistin, sulbactam and tigecycline tested alone and in combination against extensively drug-resistant Acinetobacter baumannii. Dong X; Chen F; Zhang Y; Liu H; Liu Y; Ma L J Antibiot (Tokyo); 2014 Sep; 67(9):677-80. PubMed ID: 25095805 [TBL] [Abstract][Full Text] [Related]
12. Clinical and in vitro efficacy of colistin plus vancomycin and rifampin against colistin-resistant Acinetobacter baumannii causing ventilator-associated pneumonia. Oliva A; Cipolla A; Vullo V; Venditti M; Mastroianni CM; Falcone M New Microbiol; 2017 Jul; 40(3):205-207. PubMed ID: 28675246 [TBL] [Abstract][Full Text] [Related]
13. Mutant prevention concentration of colistin alone and in combination with levofloxacin or tobramycin against multidrug-resistant Acinetobacter baumannii. Cai Y; Yang J; Kan Q; Nie X; Wang R; Liang B; Bai N Int J Antimicrob Agents; 2012 Nov; 40(5):477-8. PubMed ID: 22871371 [No Abstract] [Full Text] [Related]
14. Lipopolysaccharide loss produces partial colistin dependence and collateral sensitivity to azithromycin, rifampicin and vancomycin in Acinetobacter baumannii. García-Quintanilla M; Carretero-Ledesma M; Moreno-Martínez P; Martín-Peña R; Pachón J; McConnell MJ Int J Antimicrob Agents; 2015 Dec; 46(6):696-702. PubMed ID: 26391380 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of colistin versus beta-lactams, aminoglycosides, and rifampin as monotherapy in a mouse model of pneumonia caused by multiresistant Acinetobacter baumannii. Montero A; Ariza J; Corbella X; Doménech A; Cabellos C; Ayats J; Tubau F; Ardanuy C; Gudiol F Antimicrob Agents Chemother; 2002 Jun; 46(6):1946-52. PubMed ID: 12019113 [TBL] [Abstract][Full Text] [Related]
16. Synergistic effect of two antimicrobial peptides, Nisin and P10 with conventional antibiotics against extensively drug-resistant Acinetobacter baumannii and colistin-resistant Pseudomonas aeruginosa isolates. Jahangiri A; Neshani A; Mirhosseini SA; Ghazvini K; Zare H; Sedighian H Microb Pathog; 2021 Jan; 150():104700. PubMed ID: 33346078 [TBL] [Abstract][Full Text] [Related]
17. Emergence of rifampicin, tigecycline, and colistin-resistant Acinetobacter baumannii in Iran; spreading of MDR strains of novel International Clone variants. Bahador A; Taheri M; Pourakbari B; Hashemizadeh Z; Rostami H; Mansoori N; Raoofian R Microb Drug Resist; 2013 Oct; 19(5):397-406. PubMed ID: 23768166 [TBL] [Abstract][Full Text] [Related]
18. Dissecting Colistin Resistance Mechanisms in Extensively Drug-Resistant Acinetobacter baumannii Clinical Isolates. Trebosc V; Gartenmann S; Tötzl M; Lucchini V; Schellhorn B; Pieren M; Lociuro S; Gitzinger M; Tigges M; Bumann D; Kemmer C mBio; 2019 Jul; 10(4):. PubMed ID: 31311879 [TBL] [Abstract][Full Text] [Related]
19. Interactions of colistin and rifampin on multidrug-resistant Acinetobacter baumannii. Giamarellos-Bourboulis EJ; Xirouchaki E; Giamarellou H Diagn Microbiol Infect Dis; 2001 Jul; 40(3):117-20. PubMed ID: 11502379 [TBL] [Abstract][Full Text] [Related]
20. [Various antibiotic combinations against carbapenem resistant Acinetobacter baumannii infections and in vitro synergy test results (2002-2016)]. Zarakolu P; Ayaz ÇM; Metan G Mikrobiyol Bul; 2018 Apr; 52(2):190-197. PubMed ID: 29933736 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]